← Back to Entity Graph

The Trustee For Royal Melbourne Hospital Neuroscience Foundation

Concentration Risk
FoundationRegistryABN 25741608900VIC
Relationships
31
Data Sources
2
Revenue
$7.9M
Tax Payable
—
Preview
Data as of: 15 Mar 2026

About

The Royal Melbourne Hospital Neuroscience Foundation funds world-leading brain and neurological disease research conducted at The Royal Melbourne Hospital in Parkville, Victoria. With over 30 years of supporting research, the foundation aims to accelerate the translation of discoveries to patients affected by brain disease, including brain tumours, stroke, and multiple sclerosis. It supports adults and aged persons impacted by brain disease, with a focus on funding active research projects that can bring breakthroughs to patients quickly.

Giving Philosophy

The foundation funds ground-breaking research conducted directly at The Royal Melbourne Hospital, valuing projects that can be translated to patient care in the fastest way possible. It prioritises innovative research in brain tumours, stroke, and multiple sclerosis, supporting projects that demonstrate pioneering approaches to preventing, detecting, and treating brain and neurological diseases.

Wealth Source:The foundation appears to be a corporate foundation linked to The Royal Melbourne Hospital, raising funds through donations, signature events like a gala ball, and potentially corporate partnerships. It has raised $135 million to date for brain disease research.

Tips for Applicants

Applicants should focus on brain and neurological disease research that can be conducted at or in partnership with The Royal Melbourne Hospital. Highlighting the potential for rapid translation from research to patient care, and demonstrating alignment with the foundation's focus on innovative breakthroughs in brain tumour, stroke, and MS research would strengthen proposals.

Notable Grants

  • Support for brain tumour research, including a 'liquid biopsy' for glioma
  • Funding for stroke research, including improving early reperfusion and the development of Australia's first mobile stroke ambulance
  • Support for multiple sclerosis research focused on early detection and prevention of progressive disability
  • Funding for epilepsy research, including new anti-epileptic medications and the Australian Pregnancy Register
  • Contributions to Parkinson's disease research, including a deep brain stimulator program
  • Support for dementia research investigating pharmacological treatment approaches

Financial History (7 years)

YearRevenueExpensesAssetsSurplus
2023$7.9M$8.0M$8.0M$121K
2022$7.7M$6.7M$7.7M$616K
2021$7.3M$7.2M$6.8M$429K
2020$7.8M$7.8M$6.3M$-203,367
2019$7.5M$8.1M$6.7M$-606,478
2018$7.3M$8.7M$7.6M$-1,393,520
2017$8.4M$6.4M$8.7M$1.9M
0
Grants Given (AU)
$2.3M
Staff (FTE)
27
Volunteers
27
Donations Received
$552K

Community Evidence

External Evidence

Identity

GS ID
AU-ABN-25741608900
ABN
25741608900
Sector
health
Financial Year
2023

Focus Areas

Themes
healthresearch
Geography
AU-VIC
Target Recipients
medical-researchershealthcare-institutionsclinical-trials
Purposes
Health
Beneficiaries
AdultsAged

Board & Leadership

  • Professor Kate Drummond AM - Foundation Chair and Director of Neurosurgery
  • Professor Bruce Campbell - Director of Neurology

Financials

Revenue
$7.9M
Assets
$8.0M

Method

Match Confidence
registry
Cross-references
2 datasets
Match Key
ABN
Relationships
31

Matched by Australian Business Number (ABN) — high confidence. This entity was found across multiple government datasets using the same ABN.

Data Sources

ACNCFoundations

Location Intelligence

Postcode
3052
Locality
MELBOURNE UNIVERSITY
Remoteness
Major Cities of Australia
SEIFA Disadvantage
Decile 8/10
LGA
Moreland
SA2 Region
Parkville
Entities in Area
276
View on Power Map